Tag: endometrial cancer

1. In this cohort study, patients with early-stage, low-grade endometrial cancer who did not undergo hysterectomy, specifically those from racial ...

1. In patients with advanced or recurrent endometrial cancer (EC) with previous exposure to carboplatin and paclitaxel (PT), lenvatinib plus ...

Jemperli in combination with chemotherapy showed a 31% reduction in the risk of death and a 16.4-month improvement in median ...

Click here to read this study in the Lancet.  ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...

1. For patients with localized endometrial cancer recurrence, adding cisplatin to radiation therapy did not appear to improve progression-free survival ...

1. Overall survival is longer for patients receiving a combination of lenvatinib plus pembrolizumab as compared with chemotherapy treatment alone ...

Click to read this study in JAMA Network Open. 

1. Almost half of patients (47%) had either an objective response or had progression free survival for at least 6 ...

This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...

1. The median progression-free survival and overall survival was longer with lenvatinib plus pembrolizumab than with chemotherapy. 2. Clinically important ...